Blood pressure drug may boost liver cancer treatment power
NCT ID NCT07302919
Summary
This study is testing whether adding a common blood pressure medication (nicardipine) to a standard liver cancer treatment makes it work better. The standard treatment, called TACE, involves injecting tiny beads loaded with chemotherapy directly into the liver tumor. Researchers think the blood pressure drug might help stop the tumor from resisting the chemotherapy, leading to more complete tumor death. The study will involve about 152 adults with a specific type of liver cancer who cannot have surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATO CELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, 1205, Switzerland
Contact
Contact
-
Kantonsspital St. Gallen
RECRUITINGSankt Gallen, 9007, Switzerland
Contact
Contact
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.